iqbal farrukh (27 Ergebnisse)

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. pp. 216 Illus.

Zustand: New. In.

Zustand: Hervorragend. Zustand: Hervorragend | Seiten: 304 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Zustand: New. In.

Zustand: New. In.

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Zustand: New. pp. 252 68:B&W 7 x 10 in or 254 x 178 mm Case Laminate on White w/Gloss Lam.

Zustand: New. This study documents how Indonesia came relativley late to liberalizing its trade and investment regime and details the export-led development in the country that occured as a result. This title grew out of a World Bank/Indonesian Economic Society symposium. Editor(s): Iqbal, Farrukh; James, William E. Num Pages: 224 pages, black & white illustrations. BIC Classification: 1FMN; KCLT; KCM. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 234 x 156 x 14. Weight in Grams: 482. . 2002. hardcover. . . . . Books ship from the US and Ireland.

Hardcover. Zustand: Brand New. 208 pages. 9.25x6.25x0.75 inches. In Stock.

Zustand: New. East Asia is of interest because this region has experienced, on average, the highest economic growth rates in the world during this period. This book presents a collection of papers which examine the evolution of small and medium enterprises (hereafter SMEs) in East Asia. Editor(s): Urata, Shujiro; Iqbal, Muhammad. Num Pages: 242 pages, biography. BIC Classification: 1FP; 3JJPL; 3JJPN; 3JJPR; 3JM; KCA; KCM; KJVS. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 15. Weight in Grams: 657. . 2002. Reprinted from SMALL BUSINESS ECONOMICS, 18:1-3, . Hardback. . . . . Books ship from the US and Ireland.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Indonesia experienced strong economic growth at greatest risk, that too would be useful for strategy formulation purposes, especially in cases in the 1970s with the help of high oil prices, a where employment protection is an important period of stagnation in the 1980s when oil prices declined and another period of strong economic objective. Finally, to the extent that policies can growth after 1986 when substantial trade and alter the probability ofsuccess or failure in coping investment liberalization enabled a dramatic with shocks, it would be useful to know which of policies is most effective and under what surge in labor-intensive manufacturing export set production. Recently, the regional financial crisis conditions. of 1997-1998 dealt Indonesia a severe shock The recent crisis in East Asia provides an from which it has not yet fully recovered. How opportunity to examine the link between industrial structure and economic resilience. The relative have its SMEs done through the twists and turns of the economy in the past quarter century impact of the crisis by size of firm can be judged Unfortunately, the data needed to track the per in part by the effects on capacity utilization and formance of the SME sector are not as good for employment. The table below summarizes some Indonesia as for many of the other countries in results from a survey sponsored by the World East Asia.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Indonesia experienced strong economic growth at greatest risk, that too would be useful for strategy formulation purposes, especially in cases in the 1970s with the help of high oil prices, a where employment protection is an important period of stagnation in the 1980s when oil prices declined and another period of strong economic objective. Finally, to the extent that policies can growth after 1986 when substantial trade and alter the probability ofsuccess or failure in coping investment liberalization enabled a dramatic with shocks, it would be useful to know which of policies is most effective and under what surge in labor-intensive manufacturing export set production. Recently, the regional financial crisis conditions. of 1997-1998 dealt Indonesia a severe shock The recent crisis in East Asia provides an from which it has not yet fully recovered. How opportunity to examine the link between industrial structure and economic resilience. The relative have its SMEs done through the twists and turns of the economy in the past quarter century impact of the crisis by size of firm can be judged Unfortunately, the data needed to track the per in part by the effects on capacity utilization and formance of the SME sector are not as good for employment. The table below summarizes some Indonesia as for many of the other countries in results from a survey sponsored by the World East Asia.

Zustand: New. In.

Zustand: New. In.

Zustand: Very Good.

Zustand: New. In.

Taschenbuch. Zustand: Neu. Combating Fungal Infections | Problems and Remedy | Iqbal Ahmad (u. a.) | Taschenbuch | xx | Englisch | 2014 | Springer | EAN 9783642446726 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 560 | Sprache: Englisch | Produktart: Bücher | Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef?cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi?ed and validated.

Gebunden. Zustand: New. .Primariliy, this book is dedicated, but also highly recommended, to students, teachers and researchers enganged in universities, R&D insitutions, pharmaceutical or herbal industry, as well as health organizations. Advances in Food Sciences, 07/2007| Die.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi ed and validated.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi ed and validated.

Buch. Zustand: Neu. Neuware - This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere.

Hardcover. Zustand: Brand New. 539 pages. 9.25x6.25x1.25 inches. In Stock.